首页> 外文期刊>Neuro-Oncology >High p-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression
【24h】

High p-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression

机译:高p-catenin / Tcf-4活性通过直接调节AKT2基因表达赋予神经胶质瘤进展

获取原文
获取原文并翻译 | 示例
           

摘要

Recent data suggest that the p-catenin/Tcf-4 signaling pathway plays an important role in human cancer tumorigenesis. However, the mechanism of P-catenin/ Tcf-4 signaling in tumorigenesis is poorly understood. In this study, we show that Tcf-4 protein levels were significantly elevated in high-grade gliomas in comparison with low-grade gliomas and that Tcf-4 levels correlated with levels of AKT2. Reduction of p-catenin/Tcf-4 activity inhibited glioma cell proliferation and invasion in vitro and tumor growth in vivo. This effect of β-catenin/Tcf-4 activity was mediated by AKT2, and in vivo binding of P-catenin/Tcf-4 to the AKT2 promoter was validated using the chromatin immunoprecipitation assay and luciferase reporter assays. Taken together, we have demonstrated that Tcf-4 is associated with glioma progression and that AKT2 is a new member of the genes that are regulated by P-catenin/Tcf-4.
机译:最近的数据表明,p-catenin / Tcf-4信号通路在人类癌症的发生中起着重要的作用。然而,对P-catenin / Tcf-4信号传导在肿瘤发生中的机制了解甚少。在这项研究中,我们表明与低度神经胶质瘤相比,高度神经胶质瘤中Tcf-4蛋白水平显着升高,并且Tcf-4水平与AKT2水平相关。 p-catenin / Tcf-4活性的降低抑制了神经胶质瘤细胞的体外增殖和侵袭以及体内肿瘤的生长。 β-catenin/ Tcf-4活性的这种作用是由AKT2介导的,并且使用染色质免疫沉淀测定法和荧光素酶报告基因测定法验证了P-catenin / Tcf-4与AKT2启动子的体内结合。综上所述,我们已经证明Tcf-4与神经胶质瘤的发展有关,而AKT2是P-catenin / Tcf-4调控的基因的新成员。

著录项

  • 来源
    《Neuro-Oncology》 |2011年第6期|p.600-609|共10页
  • 作者单位

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029;

    Department of Neurosurgery, Tiantan Hospital, Capital Medical University, Beijing 100050, China;

    Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

    Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology,Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    glioma; 3-catenin; tcf-4; akt2.;

    机译:胶质瘤3-连环蛋白;tcf-4;akt2。;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号